Delphine Averseng-Peaureaux1, Marie Mizzi2, Helene Colineaux3, Laurence Mahieu4, Maria Carmela Pera5,6, David Brassat7, Yves Chaix8, Emilie Berard3, Kumaran Deiva5,6, Emmanuel Cheuret2. 1. Department of Neurology, Hôpital Pierre Paul Riquet, CHU Purpan, Toulouse, France. 2. Department of Pediatric Neurology, Hôpitaldes Enfants, CHU Purpan, Toulouse, France. 3. Department of Public Health and Epidemiology, Hôpital Purpan and Toulouse III University, Toulouse, France. 4. Department of Ophthalmology, Retinal Center, Hôpital Pierre Paul Riquet, CHU Purpan, Toulouse, France. 5. Department of Pediatric Neurology, Assistance Publique-Hôpitaux de Paris, Hopitaux Universitaires Paris-Sud, Hôpital Bicêtre, National Referral Center for Neuro-Inflammatory Diseases in Children, Paris, France. 6. Université Paris-Sud, UMR 1184, CEA, IDMIT, Center for Immunology of Viral Infections and Autoimmune Diseases, Paris, France. 7. Centre Hospitalier Universitaire Toulouse, Pole des Neurosciences, CPTP INSERM UMR 1043 et Université de Toulouse, Toulouse, France. 8. Inserm, Imagerie Cérébrale et Handicaps Neurologiques UMR 825, Université de Toulouse III - Paul Sabatier, Toulouse, France.
Authors: Soren Jonzzon; Leena Suleiman; Andrew Yousef; Brenda Young; Janace Hart; Patrick Peschl; Markus Reindl; Kristin L Schaller; Jeffrey L Bennett; Emmanuelle Waubant; Jennifer S Graves Journal: J Child Neurol Date: 2019-09-30 Impact factor: 1.987